4 unknown. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow nifekalant: new trials by email Literature Review of nifekalant trials Research Report on nifekalant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery Nifekalant, Amiodarone - New Onset Atrial Fibrillation, Complications; Cardiac, Postoperative | Phase 3 | Unknown | Beijing Anzhen Hospital | 274 | 2022-05-29 | 2024-06-03 |
| Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection Nifekalant hydrochloride - Ventricular Tachycardia, Ventricular Fibrillation | Unknown | Sichuan Baili Pharmaceutical Co., Ltd. | 2000 | 2019-02-18 | 2019-03-14 | |
| Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. Nifekalant hydrochloride, Amiodarone - Ventricular Tachycardia, Ventricular Fibrillation | Phase 4 | Unknown | Sichuan Baili Pharmaceutical Co., Ltd. | 756 | 2019-01-15 | 2019-02-27 |
| Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation nifekalant - Atrial Fibrillation | Phase 4 | Unknown | Second Affiliated Hospital of Nanchang University | 300 | 2019-01-01 | 2019-12-24 |
Tachycardia, Ventricular (2) · Ventricular Fibrillation (2) · Atrial Fibrillation (1)
Sichuan Baili Pharmaceutical Co., Ltd. (2) · Beijing Anzhen Hospital (1) · Second Affiliated Hospital of Nanchang University (1)
China (4)
Jing Zhou (1) · Ling Ya Han (1) · Min Yi Cui (1) · Xiaotong Hou, MD, PhD (1) · Xin Hu (1) · Yong Huo (1)